	Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study. PLoS One Ueda T, Fukushima K, Chi S, Haeno H, Yoshimoto G, Arai H, Ikeda D, Ichikawa M, Takahashi N, Hosono N, Yamauchi T, Kondo T, Kusumoto S, Kuroda J, Minami Y. PMID: 42821569 [PubMed - indexed for MEDLINE]
	Person-Based Progression in Acute Myeloid Leukemia Classification: A Multi-View Convolutional Neural Network Approach. J Imaging Inform Med Erda. PMID: 42823569 [PubMed - as supplied by publisher]
	Comparative Cost and Utilization Analysis of CAR-T Therapy and Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma in Germany: Insights from Statutory Health Insurance Billing and Nationwide Inpatient Data. J Cancer Res Clin Oncol Froitzheim AC, Kurte MS, Gehrke K, Lempfert S, Hesse K, Kron F. PMID: 42823558 [PubMed - indexed for MEDLINE]
	Genetic Association of MMP-13 rs2252070 and rs478927 Polymorphisms With Childhood Acute Lymphoblastic Leukemia in Taiwan. Anticancer Res Hsu PC, Tsai CL, Pei JS, Chen CC, Lin P, Jeyabal N, Chang WS, Bau DT, Tsai CW. PMID: 42823181 [PubMed - indexed for MEDLINE]
	Interleukin-4 Genetic Polymorphisms Predict Susceptibility to Childhood Acute Lymphoblastic Leukemia. Anticancer Res Chen CC, Pei JS, Chien WC, Hsu PC, Su MY, Lin ML, Chang WS, Bau DT, Tsai CW. PMID: 42823151 [PubMed - indexed for MEDLINE]
	Nodal large B-cell lymphoma with intrasinusoidal growth: a clinicopathologic study of a distinctive pattern with diagnostic overlap with intravascular large B-cell lymphoma. Hum Pathol Kim H, Na S, Jeon YK, Lee JO, Kim SA, Lee JY, Lee S, Yun H, Paik JH. PMID: 42822732 [PubMed - as supplied by publisher]
	First reported human Castellaniella defragrans bacteraemia: a case report. Swiss Med Wkly Nédellec M, Cerruti T, Jacot D, Greub G, Benmachiche M. PMID: 42821876 [PubMed - indexed for MEDLINE]
	Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial. Blood Grommes C, Nayak L, Kallam A, Peereboom D, Ambady P, Mendez JS, Aregawi D, Sumrall A, Omuro A, Iwamoto FM, Dietrich J, Umemura Y, Munker R, Chukwueke UN, Schaff LR, Ip A, Gupta NK, Drappatz J, Venur VA, Peters KB, Ho KG, Merrell R, Prados S, Takazawa A, Aoi A, Batchelor TT. PMID: 42821736 [PubMed - as supplied by publisher]
	FLT3-Mutated AML: Transplanting with Precision in the Targeted Era. Curr Hematol Malig Rep Mort JF, Ambinder AJ. PMID: 42821026 [PubMed - indexed for MEDLINE]
	FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma. Clin Cancer Res Ershler R, Zhou X, Peh KH, Wei H, Chatterjee S, Jiang X, Liu J, Okusanya OO, Shen YL, Kormanik N, Carioti T, de Claro RA, Kanapuru B, Gormley NJ, Kasamon YL. PMID: 42820870 [PubMed - as supplied by publisher]
	Clinical outcomes in pediatric acute lymphoblastic leukemia: a retrospective cohort study from a tertiary center in Indonesia. Front Pediatr Sari DP, Ayu DR, Indra RM, Rahmawati E. PMID: 42819289 [PubMed]
	Case Report: Frontline CD19 CAR-T-cell therapy combined with targeted regimens induces durable complete remission in newly diagnosed secondary CNS lymphoma: a report of two cases. Front Oncol Pan Q, Zhao R, Yang J, Guo H, Gao F, Liu X, Zhang Q, Jiao X, Zhou K. PMID: 42819140 [PubMed]
	Case Report: Successful treatment of mixed-phenotype acute leukemia with cauda equina syndrome as the initial manifestation. Front Oncol Xu X, Zhang P, Zhang J, Zheng L, Wang Y, Wang P, Ding Y, Tan Y, Xu S, Wei L. PMID: 42819101 [PubMed]
	Glycosylation converts CD24 from a developmental marker into a glyco-immune checkpoint in B-cell acute lymphoblastic leukemia. Front Immunol Yan S, Zhang X. PMID: 42819032 [PubMed - indexed for MEDLINE]
	Delayed Uptake on (123)I-IMP SPECT as a Diagnostic Clue in Cranial Vault Lymphoma in a 25-Year-Old Man: A Case Report. Clin Case Rep Sakaeyama Y, Fuchinoue Y, Abe M, Kubota S, Matsuzaki R, Terazono S, Sugo N. PMID: 42818908 [PubMed]
	Targeting leukemia stem cells in unfit acute myeloid leukemia with a CD70-directed third agent: promise and caveats from the ELEVATE trial. Comment on: "Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study". Haematologica Lyu T, Zhang Y. PMID: 42817840 [PubMed - as supplied by publisher]
	Low-Dose Cytarabine Plus G-CSF Induction in Pediatric M2 Acute Myeloid Leukemia: A Multicenter Study. Cancer Med Ou W, Zhu X, Lu J, Wang H, Liao N, Liu Y, Jiang H, An Q, Yuan X, He H, Wang N, Luo J, Ju X, Wang QF, Yang M, Cheng C, Xiao P, Yang L, Gao L, Ribeiro RC, Hu S, Zhai X. PMID: 42817041 [PubMed - indexed for MEDLINE]
	Biopsy-proven inflammatory pulmonary opacities mimicking lymphoma relapse after CD19 CAR-T-cell therapy. J Clin Exp Hematop Okuhiro K, Nishikawa T, Kodama Y, Iwanaga M, Haruyama T, Katayama O, Honda S, Moroga Y, Takano K, Nishida H, Ogata M. PMID: 42816413 [PubMed - indexed for MEDLINE]
	Retained epcoritamab activity despite routine CD20 assay negativity approximately one terminal half-life after mosunetuzumab in B-cell lymphoma. J Clin Exp Hematop Kakiuchi S, Akiyama H, Tomigaki N, Sakamoto A, Fujioka S, Harima I, Niwa R, Takagi I, Kozuki Y, Miyata Y, Iwata N, Otani K. PMID: 42816411 [PubMed - indexed for MEDLINE]
	Clonality patterns of IGH and TCRB gene rearrangement across lymphoma and non-lymphoma: a pitfall in the interpretation of multiplex PCR. J Clin Exp Hematop Fujikawa M, Miyata-Takata T, Kitadate A, Okuno N, Kunisawa T, Yamamoto S, Kikuchi S, Sato T, Takahashi N, Takata K. PMID: 42816410 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 170580

Page 1 of 8529



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy